New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2018, Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV
View latest version (2018)Bibliographic information
GuidelineAntiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach 2010 revision
Year of Publication2010
Issuing InstitutionWHO
Recommendation
Retired
For children between 12 and 24 months of age, not exposed to non-nucleoside reverse transcriptase inhibitor (NNRTI) , start ART with nevirapine (NVP) + 2 nucleoside reverse transcriptase inhibitor (NRTI)
Recommended in favor
Strong
Certainty of evidence
Moderate